Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques

Vaccine

Volumn 19, Issue 32, 2001, Pages 4865-4873

  Loomis Huff, Jennifer E ^a   Eberle, R ^b   Lockridge, Kristen M ^a   Rhodes, Gary ^a   Barry, Peter A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

B virus; Cercopithecine herpesvirus 1; DNA vaccination; Macaca mulatta

Indexed keywords

DNA VACCINE; GLYCOPROTEIN B; HERPES VACCINE; IMMUNOGLOBULIN G2A; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HERPES VIRUS; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; OCCUPATIONAL HAZARD; PLASMID; PRIORITY JOURNAL; RHESUS MONKEY; VACCINATION; VIRUS INFECTION;

ANIMAL HUSBANDRY; ANIMALS; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, SYNTHETIC; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MACACA MULATTA; MICE; MICE, INBRED BALB C; MIDDLE AGED; MONKEY DISEASES; NEUTRALIZATION TESTS; OCCUPATIONAL DISEASES; PROMOTER REGIONS (GENETICS); VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0035860627     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00232-8     Document Type: Article

References (73)

1. The simian herpesviruses
2. A cross sectional survey for B virus antibody in a colony of group housed rhesus macaques
3. Biology of B virus in macaques and human hosts: A review
4. Cercopithecine Herpes Virus 1 (B virus)
5. B virus, Herpesvirus simiae: Historical perspective
6. Guidelines for the prevention and treatment of B-virus infections in exposed persons
7. Fatal Cercopithecine herpesvirus 1 (B virus) infection following a mucocutaneous exposure and interim recommendations for worker protection
8. The herpes encephalitis problem
9. Acute ascending myelitis following a monkey bite, with the isolation of a virus capable of reproducing the disease
10. B-virus specific-pathogen-free breeding colonies of macaques (Macaca mulatta): Retrospective study of seven years of testing
11. B virus-specific pathogen-free (SPF) breeding colonies of macaques: Issues, surveillance, and results in 1992
12. AIDS research. Vaccine studies stymied by shortage of animals
13. B virus vaccines
14. Postexposure immunoprophylaxis against B virus (Herpesvirus simiae) infection
15. Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D
16. Herpes simplex virus vaccines
17. A recombinant glycoprotein vaccine for herpes simplex virus type 2: Safety and immunogenicity
18. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection
19. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial
20. DNA vaccines
21. Immune pathways used in nucleic acid vaccination
22. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection
23. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2
24. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines
25. Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene
26. DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes
27. DNA immunization of neonates induces immunity despite the presence of maternal antibody
28. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease
29. Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration
30. Protective immune correlates can segregate by vaccine type in a murine herpes model system
31. Herpes simplex virus DNA vaccine efficacy: Effect of glycoprotein D plasmid constructs
32. DNA immunization in nonhuman primates against rabies virus
33. Protection from pathogenic SIV challenge using multigenic DNA vaccines
34. Simian immunodeficiency virus DNA vaccine trial in macaques
35. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
36. Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques
37. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
38. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids
39. Development of a preventive vaccine for Ebola virus infection in primates
40. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen
41. DNA vaccines
42. DNA immunization: Mechanistic studies
43. The influence of base sequence on the immunostimulatory properties of DNA
44. Genetic and functional complementation of the HSV1 UL27 gene and gB glycoprotein by simian alpha-herpesvirus homologs
45. Relatedness of glycoproteins expressed on the surface of simian herpes-virus virions and infected cells to specific HSV glycoproteins
46. Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera
47. Analysis of the IgM and IgG antibody response against herpes simplex virus type 1 (HSV-1) structural and nonstructural proteins
48. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions
49. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions
50. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells
51. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
52. Characterization of virus-specific and cross-reactive monoclonal antibodies to Herpesvirus simiae (B virus)
53. Herpesvirus papio 2: Alternative antigen for use in monkey B virus diagnostic assays
54. Pathogenesis of experimental rhesus cytomegalovirus infection
55. DNA immunization: Effect of secretion of DNA-expressed hemagglutinins on antibody responses
56. Biological features of genetic immunization
57. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model
58. Chromatographic fractionation of rhesus monkey (Macaca mulatta) IgG subclasses using DEAE cellulose and protein A-sepharose
59. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge
60. Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum
61. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization
62. Nucleic acid immunization: Concepts and techniques associated with third generation vaccines
63. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates
64. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV
65. Immunization of non-human primates with DNA vaccines
66. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
67. Intradermal DNA immunization by using jet-injectors in mice and monkeys
68. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids
69. Immunization against SIVmne in macaques using multigenic DNA vaccines
70. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes
71. Tipping the scales of herpes simplex reactivation: The important responses are local
72. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection
73. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys